Cytosine arabinoside in the treatment of herpes simplex and chickenpox
Pytel-Dabrowska, T.; Balcar-Boroń, A.; Nowaczyk-Michalak, A.
Wiadomosci Lekarskie 33(12): 957-959
1980
ISSN/ISBN: 0043-5147 PMID: 6932786 Document Number: 163453
Document emailed within 1 workday
Related Documents
Nutter, R.L.; Rapp, F. 1973: The effect of cytosine arabinoside on virus production in various cells infected with herpes simplex virus types 1 and 2 Cancer Research 33(1): 166-170Roubal, J.; Závada, V.; Vejsada, J.; Boldogh, I.; Vonka, V. 1979: Effects of cytosine arabinoside on the incorporation of pyrimidine nucleosides into hamster cells transformed by herpes simplex type 1 and type 2 viruses and by human cytomegalovirus Acta Virologica 23(4): 314-318
Goudsmit, R. 1972: Cytosine arabinoside in the treatment of severe herpes zoster and varicella Nederlands Tijdschrift Voor Geneeskunde 116(5): 200
Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Tatsumi, N.; Masaoka, T.; Ueda, Y.; Senda, N. 1970: Treatment of leukemia with cytosine arabinoside--on the intensification of remission Gan no Rinsho. Japan Journal of Cancer Clinics 16(7): 706-712
Madon, E.; Baroncelli, P.G.; Sacerdote, A.; Roberi, P.L. 1971: Treatment of acute leukemias in the infancy with cytosine arabinoside Minerva Pediatrica 23(26): 1125-1129
Derulska, D.; Rokicka-Milewska, R. 1975: Cytosine arabinoside in the treatment of acute leukemia in children Pediatria Polska 50(6): 723-728
Klener, P.; Háber, J. 1985: Treatment of refractory leukemia with high-dose cytosine arabinoside Neoplasma 32(1): 113-117
Wdzieczak-Bakala, J.; Guigon, M.; Lenfant, M.; Frindel, E. 1983: Further purification of a CFU-S inhibitor: in vivo effects after cytosine arabinoside treatment Biomedicine and PharmacoTherapy 37(9-10): 467-471
Pedersen, G.; Stentoft, J.; Pedersen, J.O.; Jensen, M.K. 1994: Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside Ugeskrift for Laeger 156(43): 6380-6384
Nemet, D.; Labar, B.; Bogdanić, V.; Hauptman, E.; Jaksić, B.; Minigo, H.; Sertić, D.; Mrsić, M.; Pavletić, Z.; Kovacević, J. 1989: High dose cytosine arabinoside in the treatment of adult acute myelogenous leukaemia Bone Marrow Transplantation 4(Suppl 3): 42-44
Gingrich, R.D.; Armitage, J.O.; Burns, C.P. 1978: Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone Cancer Treatment Reports 62(9): 1389-1391
Kobayashi, S.; Sakai, H.; Tomiazwa, T.; Koiso, H.; Kim, K.; Ueki, K.; Tamura, J.; Yano, S.; Naruse, T.; Karasawa, M. 1999: Successful low-dose cytosine arabinoside treatment in a patient with acute leukemia from idiopathic myelofibrosis Journal of Medicine 30(1-2): 101-109
Huang, M.E.; Ye, Y.C.; Zhao, L. 1987: Treatment of acute promyelocytic leukemia by retinoic acid with or without low dose cytosine arabinoside: report of 4 cases Zhonghua Nei Ke Za Zhi 26(6): 330
Harakati, M.S. 1999: Cytosine arabinoside, mitoxantrone, and etoposide in the treatment of adult patients with previously untreated acute myeloid leukemia Saudi Medical Journal 20(4): 291-295
Cannistra, S.A.; DiCarlo, J.; Groshek, P.; Kanakura, Y.; Berg, D.; Mayer, R.J.; Griffin, J.D. 1991: Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia Leukemia 5(3): 230-238
Nouri, K.; Ricotti, C.A.; Bouzari, N.; Chen, H.; Ahn, E.; Bach, A. 2006: The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide Journal of Drugs in Dermatology: Jdd 5(2): 182-185
Maeglin, B. 1987: Herpes simplex. Oral and peroral infection with Herpes simplex virus Schweizer Monatsschrift für Zahnmedizin 97(12): 1532-1536